Wellesley Pharmaceuticals, LLC was founded to ensure that the ability of Nocturol to reduce and sometimes eliminate Nocturia symptoms can be disseminated to help the people who can benefit from it.
© Proactive Investors 2019
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.